C

Co-Diagnostics
D

CODX

0.23000
USD
-0.03
(-11.27%)
مغلق
حجم التداول
279
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
7,753,882
أصول ذات صلة
A
AEMD
-0.01600
(-3.95%)
0.38900 USD
B
BNGO
0.00000
(0.00%)
3.70000 USD
I
IBIO
-0.00110
(-0.14%)
0.80700 USD
I
INO
-0.06000
(-2.98%)
1.95500 USD
L
LAKE
-0.565
(-3.01%)
18.220 USD
MRNA
MRNA
-0.820
(-3.03%)
26.280 USD
N
NVAX
-0.04000
(-0.55%)
7.25000 USD
O
OPK
-0.01500
(-1.18%)
1.25500 USD
V
VIR
-0.11500
(-2.49%)
4.50500 USD
المزيد
الأخبار المقالات

العنوان: Co/Diagnostics

القطاع: Healthcare
الصناعة: Medical Devices
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detectionand/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.